Elevated expressions of Survivin and VEGF proteins are strong independent predictors of survival in squamous carcinoma of larynx

Chinese-German Journal of Clinical Oncology

Volumn 7, Issue 11, 2008, Pages 661-665

  Luo, Rong ^a   Kong, Weijia ^a   Wang, Yanjun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Squamous carcinoma of larynx; Survivin; VEGF

Indexed keywords

EID: 56449090868     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-008-0128-6     Document Type: Article

References (17)

1. Lu B, Mu Y, Cao C, et al. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res, 2004, 64: 2840-2845.
2. Kawasaki H, Toyoda M, Shinohara H, et al. Expression of Survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer, 2001, 91: 2026-2032.
3. Kato J, Kuwabara Y, Mitani M, et al. Expression of Survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy. Int J Cancer, 2001, 95: 92-95.
4. Yin RT, Peng ZL, Yang KX, et al. Survivin expression in ovarian carcinoma. J Sichuan Univ (Chinese), 2006, 37: 215-217.
5. Wang YJ, Kong WJ, Xiong XG, et al. The expressions of Survivin and VEGF in squamous cell carcinoma of larynx and the correlation between the two marks. J Clin Otorhinolaryngol (Chinese), 2005, 19:838-841.
6. Fan LF, Dong WG, Jiang CQ, et al. Role of Hypoxia-inducible factor-1alpha and Survivin in colorectal carcinoma progression. Int J Colorectal Dis, 2008, 23: 1057-1064.
7. Nassar A, Sexton D, Cotsonis G, et al. Survivin expression in breast carcinoma: Correlation with apoptosis and prognosis. Appl Immunohistochem Mol Morphol, 2008, 16: 221-226.
8. Liu L, Zhang M, Zou P. Expression of PLK1 and Survivin in diffuse large B-cell lymphoma. Leuk Lymphoma, 2007, 48: 2179-2183.
9. Knutsen A, Adell G, Sun XF. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy. Int J Radiat Oncol Biol Phys, 2004, 60: 149-155.
10. Goodsell DS. The molecular perspective: VEGF and angiogenesis. Stem Cells, 2003, 21: 118-119.
11. Du JD, Sun XF, Tian CZ, et al. Expression of Survivin, Caspase-3 and p53 in surgical margin of laryngeal squamous cell carcinoma and their relationship. J Clin Otorhindaryngol Head Neck Surg (Chinese), 2008, 22: 117-118.
12. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol, 2005, 23:1011-1027.
13. Seiwert TY, Cohen EE. Targeting angiogenesis in head and neck cancer. Semin Oncol, 2008, 35: 274-285.
14. Kyzas PA, Stefanou D, Batistatou A, et al. Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol, 2005, 131: 624-630.
15. Woenckhaus J, Steger K, Werner E, et al. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol, 2002, 198: 335-342.
16. Beierle EA, Nagaram A, Dai W, et al. VEGF-mediated Survivin expression in neuroblastoma cells. J Surg Res, 2005, 127: 21-28.
17. Tran J, Rak J, Sheehan C, et al. Marked induction of the IAP family antiapoptotic proteins Survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun, 1999, 264: 781-788.